Clinical Cancer Research, Vol 4, Issue 7 1603-1608, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer

H Ito, S Kyo, T Kanaya, M Takakura, M Inoue and M Namiki
Department of Urology, School of Medicine, Kanazawa University, Ishikawa, Japan.

The activation of telomerase and stabilization of telomeres are thought to be required for cellular immortality and oncogenesis. Three major components of human telomerase--human telomerase RNA (hTERC), telomerase-associated protein (TEP1), and human telomerase catalytic subunit (hTERT)-have recently been identified. However, the roles played by these subunits in the regulation of telomerase activity are still unclear. In the present study, a total of 37 urothelial cancers, including one metastatic lesion, and adjacent normal tissues as well as cell lines derived from bladder cancers were examined for the expression of each telomerase subunit. Reverse transcription-PCR analysis revealed that more than 90% of urothelial cancers expressed hTERT mRNA, whereas less than 20% of normal adjacent tissues did. In contrast, hTERC and TEP1 mRNA were commonly expressed in both cancers and normal tissues. All of the three cell lines derived from bladder cancer expressed each of the telomerase subunits, whereas the two normal primary fibroblast cell lines expressed hTERC and TEP1 mRNA but not hTERT mRNA. Telomerase activity was examined using telomeric repeat amplification protocol assay. All of the cancers examined exhibited telomerase activity, whereas only 2 of 12 normal tissues exhibited weak activity. There was a significant association of telomerase activity with hTERT mRNA expression but not with hTERC or TEP1 mRNA expression. These findings provide strong evidence that the expression of hTERT is a rate-limiting determinant of the enzymatic activity of human telomerase and that the up-regulation of hTERT expression may play a critical role in human carcinogenesis.

This article has been cited by other articles:

				M. Hanke, I. Kausch, G. Dahmen, D. Jocham, and J. M. Warnecke Detailed Technical Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder Cancer Clin. Chem., December 1, 2007; 53(12): 2070 - 2077. [Abstract] [Full Text] [PDF]

				G.-S. Shieh, A.-L. Shiau, Y.-T. Yo, P.-R. Lin, C.-C. Chang, T.-S. Tzai, and C.-L. Wu Low-Dose Etoposide Enhances Telomerase-Dependent Adenovirus-Mediated Cytosine Deaminase Gene Therapy through Augmentation of Adenoviral Infection and Transgene Expression in a Syngeneic Bladder Tumor Model. Cancer Res., October 15, 2006; 66(20): 9957 - 9966. [Abstract] [Full Text] [PDF]

				M. Takakura, S. Kyo, M. Inoue, W. E. Wright, and J. W. Shay Function of AP-1 in Transcription of the Telomerase Reverse Transcriptase Gene (TERT) in Human and Mouse Cells Mol. Cell. Biol., September 15, 2005; 25(18): 8037 - 8043. [Abstract] [Full Text] [PDF]

				J. Kamizono, S. Nagano, Y. Murofushi, S. Komiya, H. Fujiwara, T. Matsuishi, and K.-i. Kosai Survivin-Responsive Conditionally Replicating Adenovirus Exhibits Cancer-Specific and Efficient Viral Replication Cancer Res., June 15, 2005; 65(12): 5284 - 5291. [Abstract] [Full Text] [PDF]

				T. Fukazawa, Y. Maeda, F. M. Sladek, and L. B. Owen-Schaub Development of a Cancer-Targeted Tissue-Specific Promoter System Cancer Res., January 1, 2004; 64(1): 363 - 369. [Abstract] [Full Text] [PDF]

				S. Kyo, M. Nakamura, T. Kiyono, Y. Maida, T. Kanaya, M. Tanaka, N. Yatabe, and M. Inoue Successful Immortalization of Endometrial Glandular Cells with Normal Structural and Functional Characteristics Am. J. Pathol., December 1, 2003; 163(6): 2259 - 2269. [Abstract] [Full Text]

				K. Kraemer, S. Fuessel, U. Schmidt, M. Kotzsch, B. Schwenzer, M. P. Wirth, and A. Meye Antisense-mediated hTERT Inhibition Specifically Reduces the Growth of Human Bladder Cancer Cells Clin. Cancer Res., September 1, 2003; 9(10): 3794 - 3800. [Abstract] [Full Text] [PDF]

				X. Yi, J. W. Shay, and W. E. Wright Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells Nucleic Acids Res., December 1, 2001; 29(23): 4818 - 4825. [Abstract] [Full Text] [PDF]

				Z. Wang, S. Kyo, M. Takakura, M. Tanaka, N. Yatabe, Y. Maida, M. Fujiwara, J. Hayakawa, M. Ohmichi, K. Koike, et al. Progesterone Regulates Human Telomerase Reverse Transcriptase Gene Expression via Activation of Mitogen-activated Protein Kinase Signaling Pathway Cancer Res., October 1, 2000; 60(19): 5376 - 5381. [Abstract] [Full Text]

				M. Arinaga, S. Shimizu, K. Gotoh, N. Haruki, T. Takahashi, T. Takahashi, and T. Mitsudomi Expression of human telomerase subunit genes in primary lung cancer and its clinical significance Ann. Thorac. Surg., August 1, 2000; 70(2): 401 - 405. [Abstract] [Full Text] [PDF]

				C. Poremba, C. Scheel, B. Hero, H. Christiansen, K.-L. Schaefer, J.-i. Nakayama, F. Berthold, H. Juergens, W. Boecker, and B. Dockhorn-Dworniczak Telomerase Activity and Telomerase Subunits Gene Expression Patterns in Neuroblastoma: A Molecular and Immunohistochemical Study Establishing Prognostic Tools for Fresh-Frozen and Paraffin-Embedded Tissues J. Clin. Oncol., July 1, 2000; 18(13): 2582 - 2592. [Abstract] [Full Text] [PDF]

				K. Fujimoto, S. Kyo, M. Takakura, T. Kanaya, Y. Kitagawa, H. Itoh, M. Takahashi, and M. Inoue Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT Nucleic Acids Res., July 1, 2000; 28(13): 2557 - 2562. [Abstract] [Full Text] [PDF]

				Y. Kitagawa, S. Kyo, M. Takakura, T. Kanaya, K. Koshida, M. Namiki, and M. Inoue Demethylating Reagent 5-Azacytidine Inhibits Telomerase Activity in Human Prostate Cancer Cells through Transcriptional Repression of hTERT Clin. Cancer Res., July 1, 2000; 6(7): 2868 - 2875. [Abstract] [Full Text]

				T. Günther, R. Schneider-Stock, C. Häckel, M. Pross, H.-U. Schulz, H. Lippert, and A. Roessner Telomerase Activity and Expression of hTRT and hTR in Gastrointestinal Stromal Tumors in Comparison with Extragastrointestinal Sarcomas Clin. Cancer Res., May 1, 2000; 6(5): 1811 - 1818. [Abstract] [Full Text]

				J. B. de Kok, T. J.M. Ruers, G. N.P. van Muijen, A. van Bokhoven, H. L. Willems, and D. W. Swinkels Real-Time Quantification of Human Telomerase Reverse Transcriptase mRNA in Tumors and Healthy Tissues Clin. Chem., March 1, 2000; 46(3): 313 - 318. [Abstract] [Full Text] [PDF]

				S. Kyo, M. Takakura, T. Taira, T. Kanaya, H. Itoh, M. Yutsudo, H. Ariga, and M. Inoue Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT) Nucleic Acids Res., February 1, 2000; 28(3): 669 - 677. [Abstract] [Full Text] [PDF]

				M. Takakura, S. Kyo, T. Kanaya, H. Hirano, J. Takeda, M. Yutsudo, and M. Inoue Cloning of Human Telomerase Catalytic Subunit (hTERT) Gene Promoter and Identification of Proximal Core Promoter Sequences Essential for Transcriptional Activation in Immortalized and Cancer Cells Cancer Res., February 1, 1999; 59(3): 551 - 557. [Abstract] [Full Text] [PDF]

				J. S. Knight, M. A. Cotter II, and E. S. Robertson The Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus Transactivates the Telomerase Reverse Transcriptase Promoter J. Biol. Chem., June 15, 2001; 276(25): 22971 - 22978. [Abstract] [Full Text] [PDF]